Antibodies against PsrP, a novel Streptococcus pneumoniae adhesin, block adhesion and protect mice against

Lloyd Rose1, Pooja Shivshankar, Ernesto Hinojosa

  • 1Department of Microbiology and Immunology, the University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

Insights

Pneumococcal serine-rich repeat protein (PsrP) is crucial for Streptococcus pneumoniae persistence in mouse lungs. Recombinant PsrP and antibodies against it show potential as protective antigens against pneumococcal infections.

Area of Science:

  • Microbiology
  • Immunology
  • Pathogen-host interactions

Background:

  • Streptococcus pneumoniae is a major cause of bacterial pneumonia.
  • Pneumococcal serine-rich repeat protein (PsrP) is a surface protein implicated in bacterial adhesion.

Purpose of the Study:

  • To investigate the role of PsrP in Streptococcus pneumoniae pathogenesis.
  • To determine the specific function and anatomical site-specificity of PsrP during infection.

Main Methods:

  • In vivo mouse models of infection (lung challenge, nasopharyngeal colonization, sepsis).
  • In vitro adhesion assays using various human and rodent cell lines (lung epithelial, nasopharyngeal epithelial, endothelial cells).
  • Characterization of PsrP's adhesive domains and evaluation of antibodies against recombinant PsrP.

Main Results:

  • PsrP is essential for bacterial persistence in the lungs but not for nasopharyngeal colonization or bloodstream replication.
  • PsrP mediates adhesion to lung epithelial cells, with the N-terminus being critical for this interaction.
  • Recombinant PsrP (rPsrP(SRR1-BR)) binds to lung cells and inhibits bacterial adhesion, while antibodies against it neutralize PsrP function and protect mice.

Conclusions:

  • PsrP functions as a lung-specific adhesin required for Streptococcus pneumoniae persistence.
  • Recombinant PsrP(SRR1-BR) represents a potential protective antigen for vaccine development against pneumococcal lung infections.